Sybari sets terms of IPO

Posted by   Virus Bulletin on   Jan 14, 2005

3.35 million common shares for sale

Anti-virus firm Sybari Software Inc. has set the terms of its planned initial public offering (IPO) in a filing with the Securities and Exchange Commission.

The company, which filed a registration statement with the Securities and Exchange Commission

in May 2004, plans to sell 3.35 million common shares at $14-$16 each, in order to raise proceeds of between $46.9 million and $53.6 million.

It is reported that the company intends to use $25 million of the proceeds from the sale to repay subordinated debt, redeem series A preferred stock and pay accrued dividends on preferred stock. The rest of the funds will be used for 'general purposes'.

The company shares are expected to trade on the Nasdaq under the symbol 'SYBS'.

Posted on 14 January 2005 by Virus Bulletin

 Tags

twitter.png
fb.png
linkedin.png
hackernews.png
reddit.png

 

Latest posts:

VBSpam tests to be executed under the AMTSO framework

VB is excited to announce that, starting from the Q3 test, all VBSpam tests of email security products will be executed under the AMTSO framework.

In memoriam: Prof. Ross Anderson

We were very sorry to learn of the passing of Professor Ross Anderson a few days ago.

In memoriam: Dr Alan Solomon

We were very sorry to learn of the passing of industry pioneer Dr Alan Solomon earlier this week.

New paper: Nexus Android banking botnet – compromising C&C panels and dissecting mobile AppInjects

In a new paper, researchers Aditya K Sood and Rohit Bansal provide details of a security vulnerability in the Nexus Android botnet C&C panel that was exploited in order to gather threat intelligence, and present a model of mobile AppInjects.

New paper: Collector-stealer: a Russian origin credential and information extractor

In a new paper, F5 researchers Aditya K Sood and Rohit Chaturvedi present a 360 analysis of Collector-stealer, a Russian-origin credential and information extractor.

We have placed cookies on your device in order to improve the functionality of this site, as outlined in our cookies policy. However, you may delete and block all cookies from this site and your use of the site will be unaffected. By continuing to browse this site, you are agreeing to Virus Bulletin's use of data as outlined in our privacy policy.